Perrotta, F. et al. 2020. Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study. Reumatismo. 72, 1 (Apr. 2020), 52–59. DOI:https://doi.org/10.4081/reumatismo.2020.1266.